Skip to main content
Back to all on-demand-webinar

Clinical Pharmacology & Model-Informed Drug Development Insights for Targeted Radiation Therapies

If you’re a clinical pharmacologist, pharmacometrician, discovery scientist, clinical lead, or regulatory representative working on TRTs, this webinar is a must-watch.

Key Takeaways:

  1. Clinical Pharmacology Regulatory Landscape:
    Overview of current requirements and dose optimization for TRTs.
  2. Model-Informed Drug Development (MIDD):
    Solutions for major development questions and streamlining TRT development.
  3. Quantitative Systems Pharmacology (QSP):
    Translating molecular features to predict drug properties, including biodistribution and therapeutic index.
  4. Pharmacometrics:
    Utilizing radiological/nuclear medicine imaging to predict biodistribution and absorbed doses per organ and tumor.
  5. Clinical Safety and Efficacy:
    Informing clinical outcomes and guiding dose optimization from discovery to registration.

Speakers

Amandine Manon, PharmD: Senior Director, Clinical Pharmacology and Translational Medicine at Certara.

Diane-Charlotte Imbs, PharmD, PhD: Associate Director, Clinical Pharmacology at Certara.

Joshua Apgar, PhD: VP, Global Head of ABM Scientific Affairs at Applied BioMath.

Hunter Stephens, PhD: Associate Scientist, Pharmacometrics group at Certara.

Access the Webinar Recording